Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human
about
Kir3 channel signaling complexes: focus on opioid receptor signalingμ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neuronsRepeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.Engineering endomorphin drugs: state of the art.Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal grayMechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.Endomorphin-2: a biased agonist at the μ-opioid receptor.Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific maAssessment of morphine-induced hyperalgesia and analgesic tolerance in mice using thermal and mechanical nociceptive modalities.Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatmentRegulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.Dual effect of morphine in long-term social memory in rat.Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanylPharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.A reply to 'Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study'.Molecular Pharmacology of δ-Opioid Receptors.The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.Efficacy and ligand bias at the μ-opioid receptor.Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation.μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.Transmission of pruriceptive signals.The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.Opioid dependence and substitution therapy: thymoquinone as potential novel supplement therapy for better outcome for methadone maintenance therapy substitution therapy.Dynorphin acts as a neuromodulator to inhibit itch in the dorsal horn of the spinal cord.Involvement of neuronal nitric oxide synthase in desensitisation of µ-opioid receptors in the rat locus coeruleus.Characterization of functional μ opioid receptor turnover in rat locus coeruleus: an electrophysiological and immunocytochemical study.Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (OpioidSlowly Signaling G Protein-Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence.Role of the guanine nucleotide binding protein, Gαo, in the development of morphine tolerance and dependence.An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray.Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
P2860
Q27006957-C24F7371-8B68-4C11-B713-5E700195796BQ34939720-7C44C17C-3425-4544-A94F-CDBB396AF98AQ34939968-03AD3050-AF02-47DC-B250-E88C56576112Q35660653-0E5F3AD3-0069-4DE8-8064-FBEBAD2B46B8Q36007619-C73AE9F6-443C-498F-BBB9-CDF65E67ED0DQ36025329-57298067-3807-4BA7-B4D2-2516D5F9CDFCQ36105495-DBD7E4DF-A524-4A33-9A01-D0A100FAB33EQ36385137-2A95B0A1-8B75-48C9-B7A9-1B38CB6CA020Q36407701-7443FABC-F4F5-4E6A-BF95-B5590B6D74B3Q36583588-90C1D05F-C0A7-4234-97AE-D6D1096B2887Q36591603-56D0F3D5-1DC4-4658-9C11-F5DE6EBC62C7Q36756982-5B0683D5-D5C7-4E5B-823C-79646DFDACF6Q36780862-C24D3687-B8F1-47A9-8158-BC53926F65D3Q36828445-8CA8A009-E028-47D9-AB47-7DFBAB534103Q36915341-EB79A663-7415-4AB8-83C7-71751A83C946Q37062556-3A6AFFBF-1458-48DA-85FA-DD243BB81380Q37646423-A48CD378-7192-48E6-A113-BF051AF26DB9Q37710121-1B8636CC-02E3-4B89-A68F-0071E5526124Q38104365-3A5DE338-BCED-4A74-BA16-CD993ABBBA29Q38187199-B2E12E79-47A5-4749-AFF2-EA4CC667357CQ38285112-AD2BDC9A-01E5-4C88-943D-CA158F790847Q38415092-20117576-68AB-4805-9BD3-779D36245F5EQ38664725-8C031929-D5CC-4464-A8F8-5044BC6AE67FQ39301963-4800AFFE-0C4F-4C42-B8A5-7522E6D5AD46Q39661209-AE15508E-B0EC-4FCD-8063-F399D8302B44Q44345561-8EA382D1-450A-4DC6-B374-2B2961F4D011Q44346280-8DA2AEE3-D642-461E-9E10-5C860A40403BQ47132121-BE040812-A38C-4340-995C-FE313636C664Q47344641-D70D2958-E1DE-4A01-BE57-4E95BA220BF1Q47711187-04CAEA6C-77A0-4F77-A78E-CD028A4CC170Q55646588-474448DD-288A-4C05-808F-DE3392FA9CAFQ56889524-F0867041-DFBD-403B-8AA2-985B20D293DA
P2860
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Analysis of opioid efficacy, t ...... nce from cell culture to human
@ast
Analysis of opioid efficacy, t ...... nce from cell culture to human
@en
type
label
Analysis of opioid efficacy, t ...... nce from cell culture to human
@ast
Analysis of opioid efficacy, t ...... nce from cell culture to human
@en
prefLabel
Analysis of opioid efficacy, t ...... nce from cell culture to human
@ast
Analysis of opioid efficacy, t ...... nce from cell culture to human
@en
P2860
P1476
Analysis of opioid efficacy, t ...... nce from cell culture to human
@en
P2093
MacDonald J Christie
Michael M Morgan
P2860
P304
P356
10.1111/J.1476-5381.2011.01335.X
P407
P577
2011-10-01T00:00:00Z